Translated automatically – community improvements welcome.
AD-810
Zonisamide is an anticonvulsant primarily used for the treatment of epilepsy. It acts by blocking voltage-gated sodium channels and inhibiting T-type calcium channels, which reduces neuronal excitability. Additionally, it modulates neurotransmitters such as dopamine and serotonin. The substance has neuroprotective properties and is occasionally used off-label for other neurological disorders.
Mechanism of Action
- Na+ channel blocker
- T-type Ca2+ channel inhibitor
Names / Identifiers
IUPAC: Zonisamide
Mechanism of Action
Zonisamid wirkt hauptsächlich durch die Hemmung von spannungsabhängigen Natriumkanälen und die Modulation von Calciumkanälen, was zu einer Stabilisierung der neuronalen Erregbarkeit führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Allergy to zonisamide or related substances.
- Pregnancy and breastfeeding without medical supervision.
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Schwindel, Müdigkeit und Hautausschläge.
Safer Use
- Start at a low dose.
- Conduct regular medical check-ups.
Harm reduction tips do not replace medical advice.
Known Interactions
- May interact with other antiepileptics.
- Interactions with certain antidepressants possible.
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.